Literature DB >> 29543531

Mif-deficiency favors an atheroprotective autoantibody phenotype in atherosclerosis.

Corinna Schmitz1,2, Heidi Noels2, Omar El Bounkari1, Eva Straussfeld1,2, Remco T A Megens3, Marieke Sternkopf2, Setareh Alampour-Rajabi2, Christine Krammer1, Pathricia V Tilstam2,4, Norbert Gerdes3,5, Christina Bürger3, Aphrodite Kapurniotu6, Richard Bucala4, Joachim Jankowski2,7, Christian Weber3,7,8, Jürgen Bernhagen1,8,9.   

Abstract

The inflammatory cytokine macrophage migration-inhibitory factor (MIF) promotes atherosclerosis via lesional monocyte and T-cell recruitment. B cells have emerged as important components in atherogenesis, but the interaction between MIF and B cells in atherogenesis is unknown. Here, we investigated the atherosclerotic phenotype of Mif-gene deletion in Apoe-/- mice. Apoe-/- Mif-/- mice fed a Western diet exhibited strongly reduced atherosclerotic lesions in brachiocephalic artery (BC) and abdominal aorta compared with controls. This phenotype was accompanied by reduced circulating B cells. Flow cytometry revealed a B-cell developmental defect with increased premature and immature B-cell counts in bone marrow (BM) of Apoe-/- Mif-/- mice and diminished B-cell numbers in spleen. This finding was linked with a decreased expression of Baff-R and differentiation-driving transcription factors at the immature B-cell stage, whereas peritoneal B cells exhibited unchanged CD80 and CD86 expression but vastly decreased CD9 and elevated CD23 levels, indicating that the developmental block favors the generation of immature, egressing, and reactive B cells. Mif deficiency did not affect absolute B-cell numbers in the vessel wall but favored a relative increase of B cells in the atheroprone BC region and the appearance of periadventitial B-cell-rich clusters. Of note, Mif-/- mice exhibited a significant increase in oxidized low-density lipoprotein (oxLDL)-specific antibodies after the injection of oxLDL, indicating that Mif deficiency is associated with higher sensitivity of B cells against natural-occurring antigens such as oxLDL. Importantly, Apoe-/- mice adoptively transplanted with Apoe-/-Mif-/- BM showed reduced peripheral B cells compared with Apoe-/- BM transplantation but no atheroprotection in the BC; also, whereas there was a selective increase in atheroprotective IgM-anti-oxLDL-antibodies in global Mif deficiency, BM-specific Mif deficiency also led to elevated proatherogenic anti-oxLDL-IgG. Together, these findings reveal a novel link between MIF and B cells in atherogenesis. Protection from atherosclerosis by Mif deficiency is associated with enhanced B-cell hypersensitivity, which in global but not BM-restricted Mif deficiency favors an atheroprotective autoantibody profile in atherosclerotic mice. Targeting MIF may induce protective B-cell responses in atherosclerosis.-Schmitz, C., Noels, H., El Bounkari, O., Straussfeld, E., Megens, R. T. A., Sternkopf, M., Alampour-Rajabi, S., Krammer, C., Tilstam, P. V., Gerdes, N., Bürger, C., Kapurniotu, A., Bucala, R., Jankowski, J., Weber, C., Bernhagen, J. Mif-deficiency favors an atheroprotective autoantibody phenotype in atherosclerosis.

Entities:  

Keywords:  antibody; chemokine; immunology; lymphocyte

Mesh:

Substances:

Year:  2018        PMID: 29543531      PMCID: PMC6207164          DOI: 10.1096/fj.201800058R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  53 in total

1.  IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis.

Authors:  Christoph J Binder; Karsten Hartvigsen; Mi-Kyung Chang; Marina Miller; David Broide; Wulf Palinski; Linda K Curtiss; Maripat Corr; Joseph L Witztum
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

Review 2.  The transcriptional regulation of B cell lineage commitment.

Authors:  Stephen L Nutt; Barbara L Kee
Journal:  Immunity       Date:  2007-06       Impact factor: 31.745

3.  MIF promotes B cell chemotaxis through the receptors CXCR4 and CD74 and ZAP-70 signaling.

Authors:  Christina Klasen; Kim Ohl; Marieke Sternkopf; Idit Shachar; Corinna Schmitz; Nicole Heussen; Elias Hobeika; Ella Levit-Zerdoun; Klaus Tenbrock; Michael Reth; Jürgen Bernhagen; Omar El Bounkari
Journal:  J Immunol       Date:  2014-04-23       Impact factor: 5.422

4.  Antigen conjugated to anti-CD23 antibodies is rapidly transported to splenic follicles by recirculating B cells.

Authors:  H Xu; L van Mechelen; F Henningsson; B Heyman
Journal:  Scand J Immunol       Date:  2015-01       Impact factor: 3.487

5.  Transitional B lymphocyte subsets operate as distinct checkpoints in murine splenic B cell development.

Authors:  Thomas T Su; David J Rawlings
Journal:  J Immunol       Date:  2002-03-01       Impact factor: 5.422

6.  Impact of counterbalance between macrophage migration inhibitory factor and its inhibitor Gremlin-1 in patients with coronary artery disease.

Authors:  Iris I Müller; Karin A L Müller; Athanasios Karathanos; Heiko Schönleber; Dominik Rath; Sebastian Vogel; Madhumita Chatterjee; Martina Schmid; Maximilian Haas; Peter Seizer; Harald Langer; Elke Schaeffeler; Matthias Schwab; Meinrad Gawaz; Tobias Geisler
Journal:  Atherosclerosis       Date:  2014-09-30       Impact factor: 5.162

Review 7.  B-cell antigen-receptor signalling in lymphocyte development.

Authors:  Leo D Wang; Marcus R Clark
Journal:  Immunology       Date:  2003-12       Impact factor: 7.397

8.  Platelets are a previously unrecognised source of MIF.

Authors:  T Strüßmann; S Tillmann; T Wirtz; R Bucala; P von Hundelshausen; J Bernhagen
Journal:  Thromb Haemost       Date:  2013-07-11       Impact factor: 5.249

9.  IgM antibodies to apoptosis-associated determinants recruit C1q and enhance dendritic cell phagocytosis of apoptotic cells.

Authors:  Yifang Chen; Yong-Beom Park; Ekta Patel; Gregg J Silverman
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

10.  Expression of human tissue factor pathway inhibitor on vascular smooth muscle cells inhibits secretion of macrophage migration inhibitory factor and attenuates atherosclerosis in ApoE-/- mice.

Authors:  Daxin Chen; Min Xia; Claudia Hayford; El-Li Tham; Vikki Semik; Stuart Hurst; Ying Chen; Henry H Tam; Jun Pan; Yucheng Wang; Xiaojin Tan; Hui-Yao Lan; Huahao Shen; Vijay V Kakkar; Qingbo Xu; John H McVey; Anthony Dorling
Journal:  Circulation       Date:  2015-02-12       Impact factor: 29.690

View more
  9 in total

1.  Single-Cell RNA Sequencing of Peripheral Blood Mononuclear Cells From Acute Myocardial Infarction.

Authors:  Jun Qian; Yanhua Gao; Yan Lai; Zi Ye; Yian Yao; Keke Ding; Jing Tong; Hao Lin; Guoqi Zhu; Yunan Yu; Haoran Ding; Deqiang Yuan; Jiapeng Chu; Fei Chen; Xuebo Liu
Journal:  Front Immunol       Date:  2022-06-29       Impact factor: 8.786

2.  Cross-kingdom mimicry of the receptor signaling and leukocyte recruitment activity of a human cytokine by its plant orthologs.

Authors:  Dzmitry Sinitski; Katrin Gruner; Markus Brandhofer; Christos Kontos; Pascal Winkler; Anja Reinstädler; Priscila Bourilhon; Zhangping Xiao; Robbert Cool; Aphrodite Kapurniotu; Frank J Dekker; Ralph Panstruga; Jürgen Bernhagen
Journal:  J Biol Chem       Date:  2019-12-06       Impact factor: 5.486

3.  Porphyromonas gingivalis-Induced MIF Regulates Intercellular Adhesion Molecule-1 Expression in EA.hy926 Cells and Monocyte-Endothelial Cell Adhesion Through the Receptors CD74 and CXCR4.

Authors:  Yun Wu; Wanyue Xu; Jingya Hou; Yanqing Liu; Rong Li; Jingbo Liu; Chen Li; Xiaolin Tang; Li Lin; Yaping Pan; Dongmei Zhang
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

Review 4.  The Multitasking Potential of Alarmins and Atypical Chemokines.

Authors:  Aphrodite Kapurniotu; Ozgun Gokce; Jürgen Bernhagen
Journal:  Front Med (Lausanne)       Date:  2019-01-23

Review 5.  Role of the COP9 Signalosome (CSN) in Cardiovascular Diseases.

Authors:  Jelena Milic; Yuan Tian; Jürgen Bernhagen
Journal:  Biomolecules       Date:  2019-06-05

6.  Designed CXCR4 mimic acts as a soluble chemokine receptor that blocks atherogenic inflammation by agonist-specific targeting.

Authors:  Christos Kontos; Omar El Bounkari; Christine Krammer; Dzmitry Sinitski; Kathleen Hille; Chunfang Zan; Guangyao Yan; Sijia Wang; Ying Gao; Markus Brandhofer; Remco T A Megens; Adrian Hoffmann; Jessica Pauli; Yaw Asare; Simona Gerra; Priscila Bourilhon; Lin Leng; Hans-Henning Eckstein; Wolfgang E Kempf; Jaroslav Pelisek; Ozgun Gokce; Lars Maegdefessel; Richard Bucala; Martin Dichgans; Christian Weber; Aphrodite Kapurniotu; Jürgen Bernhagen
Journal:  Nat Commun       Date:  2020-11-25       Impact factor: 14.919

Review 7.  IFN-I Mediates Dysfunction of Endothelial Progenitor Cells in Atherosclerosis of Systemic Lupus Erythematosus.

Authors:  Xuewei Ding; Wei Xiang; Xiaojie He
Journal:  Front Immunol       Date:  2020-11-11       Impact factor: 7.561

8.  The Experimental Exploration of TCM Theory "Treating the Same Disease with Different Approaches" on an Ulcerative Colitis Model.

Authors:  Lulu Ni; Lingzhong Kong; Yajun Tang; Yangfan Nie; Xinyue Wang; Xue Yang; Li Zhu; Shan Jing
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-30       Impact factor: 2.650

9.  The macrophage migration inhibitory factor pathway in human B cells is tightly controlled and dysregulated in multiple sclerosis.

Authors:  Liza Rijvers; Marie-José Melief; Roos M van der Vuurst de Vries; Maeva Stéphant; Jamie van Langelaar; Annet F Wierenga-Wolf; Jeanet M Hogervorst; Anneke J Geurts-Moespot; Fred C G J Sweep; Rogier Q Hintzen; Marvin M van Luijn
Journal:  Eur J Immunol       Date:  2018-09-25       Impact factor: 5.532

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.